Skip to content

Palisade Bio, Inc.

PALI Nasdaq SEC CIK 1357459

Follow Palisade Bio Weekly email: filings, results, news

News

2 stories filed under Palisade Bio, grouped into ongoing threads

Phase

Thread · 2 stories

Palisade Bio at Stifel forum: pde4 bet advances into phase 2

Markets 1 d ago

Palisade Bio plans phase 2 ulcerative colitis trial in 2H 2026

Markets 45 d ago

Profile

Headquarters: CARLSBAD, CA, United States
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Peers

Where this page comes from

Profile · SEC EDGAR

News · 2 stories clustered from the RSS aggregator